Avadomide plus obinutuzumab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (CC-122-NHL-001): a multicentre, dose escalation and expansion phase 1 study

Jean‐Marie Michot, Réda Bouabdallah, Umberto Vitolo, Jeanette K. Doorduijn, Gilles Salles, Annalisa Chiappella, Pier Luigi Zinzani, Fontanet Bijou, Marie José Kersten, R. Sarmiento, Silvia Mosulén, Cristina Méndez, Shailaja Uttamsingh, Michael Pourdehnad, Kristen Hege, Tianlei Chen, Christian Klein, Patrick R. Hagner, Zariana Nikolova, Vincent Ribrag